Press releases
- dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
- Progress on share repurchase program to cover share plans
- dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
- dsm-firmenich announces repurchase of 1.5m shares to cover share plans
- Ad Hoc Press Release - Regulated Information
- dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
More ▼
Key statistics
On Friday, DSM-Firmenich AG (ZX61:FRA) closed at 9.30, 1.64% above its post-IPO low of 9.15, set on May 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.25 |
---|---|
High | 9.30 |
Low | 9.20 |
Bid | 9.30 |
Offer | 11.90 |
Previous close | 9.15 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 31 2024 14:29 BST.
More ▼